2. Zhang DX, Zhang LM, Zhao XC, et al. Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway. Biomed Pharmacother, 2017, 87: 332-341.
[2]
4. Rezaee MA, Mohammadpour AH, Imenshahidi M, et al. Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide. Life Sci , 2016, 148: 118-124.
[3]
6. Ranjbaran M, Kadkhodaee M, Seifi B, et al. Erythropoietin attenuates experimental haemorrhagic shock-induced renal damage through an iNOS-dependent mechanism in male Wistar rats. Injury, 2017, 48(2): 262-269.
[4]
7. Cui H, He J, Chen H, et al. Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats. Biomed Rep, 2017, 6(1): 32-38.
[5]
10. Vollmar B, Eipel C, Menger MD, Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med, 2009, 37(3): 889-898.
[6]
14. Ravikumar P, Menon JU, Punnakitikashem P, et al. Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury. Nanomedicine, 2016, 12(3): 811-821.
[7]
16. Liu Y, Lu J, Chen L, et al. Erythropoietin-derived petide protects against acute lung injury after rat traumatic brain injury . Cell Physiol Biochem, 2017, 41(5): 2037-2044.
[8]
18. Korkmaz T, Kahramansoy N, Kilicgun A, et al. The effect of erythropoietin to pulmonary injury and mast cells secondary to acute pancreatitis. BMC Research Notes, 2014, 7(1): 1-6.
[9]
21. Shang Y, Jiang YX, Xu SP, et al. Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia . Chin Med J, 2009, 122(7): 834-838.
[10]
23. Yuksel IO, Cagirci G, Koklu E, et al. Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion. Neth Heart J, 2016, 24(10): 609-616.
26. Yu DF, Zhu LH, Jiang L, et al. Recombinant human erythropoietin augments neovascularization responses in a neonatal rat model of premature brain damage by phosphatidylinositol 3 kinase/Akt pathway. Chin Med J (Engl), 2017, 130(7): 854-858.
30. MacRedmond R, Singhera GK, Dorscheid DR, et al. Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. Eur Respir J, 2009, 33(6): 1403-1414.
[15]
32. Szabó C. Multiple pathways of peroxynitrite cytotnxicity. Toxicol Lett, 2003, 140-141: 105-112.
[16]
34. Bakan V, Kurutas EB, ？？ral？k H, et al. Endogenous erythropoietin level and effects of exogenous erythropoietin in a rat model of blunt chest trauma-induced pulmonary contusion. Ulus Travma Acil Cerrahi Derg, 2016, 22(4): 322-327.
[17]
36. Jang W, Kim HJ, Li H, et al. The neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in SH-SY5Y cells through the induction of autophagy. Mol Neurobiol, 2016, 53(6): 3812-3821.
[18]
37. Luan Y, Zhang L, Chao S, et al. Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-β1 signaling. Oncotarget, 2016, 7(30): 47082-47094.
9. Wu H, Dong G, Liu H, et al. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol, 2009, 602(2-3): 406-412.
[24]
11. Fiordaliso F, Chimenti S, Staszewsky L, et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A, 2005, 102(6): 2046-2051.
[25]
12. Brines M, Grasso G, Fiordaliso F, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A, 2004, 101(41): 14907-14912.
[26]
13. Maiese K, Chong ZZ, Shang YC, et al. Raves and risks for erythropoietin. Cytokine Growth Factor Rev, 2008, 19(2): 145-155.
[27]
15. Aggarwal S, Gross CM, Kumar S, et al. Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury. Am J Respir Cell Mol Biol, 2014, 50 (3): 614-625.
[28]
17. Tascilar O, Cakmak GK, Tekin IO, et al. Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J Gastroenterol, 2007, 13(46): 6172-6182.
[29]
19. Ji MH, Tong JH, Tan YH, et al. Erythropoietin pretreatment attenuates seawater aspiration-induced acute lung injury in rats. Inflammation, 2016, 39(1): 447-456.
22. Rocha J, Eduardo-Figueira M, Barateiro A, et al. Erythropoietin reduces acute lung injury and multiple organ failure/dysfunction associated to a scald-burn inflammatory injury in the rat. Inflammation, 2015, 38(1): 312-326.
[32]
25. Heitrich M, García DM, Stoyanoff TR, et al. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation. Biomed Pharmacother, 2016, 82: 606-613.
[33]
27. Hu R, Cheng Y, Jing H, et al. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/AKT pathway. Shock, 2014, 42(4): 327-336.
33. Kakavass S, Demestiha T, Vasileiou P, et al. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury . Eur J Clin Pharmacol, 2011, 67(1): 1-9.
[37]
35. Ardalan MR, Estakhri R, Hajipour B, et al. Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung. Med Princ Pract, 2013, 22(1): 70-74.
[38]
38. Li R, Zhang LM, Sun WB. Erythropoietin rescues primary rat cortical neurons from pyroptosis and apoptosis via Erk1/2-Nrf2/Bach1 signal pathway. Brain Res Bull, 2017, 130: 236-244.
